By Melodie Warner 
 

Affymetrix Inc. (AFFX) named Gavin Wood chief financial officer and executive vice president to succeed Tim Barabe, who intends to retire June 28.

Mr. Wood joined Affymetrix in 2006 and most recently served as vice president of finance and international controller, responsible for Europe and the Asia Pacific region.

"I firmly believe that we need a CFO that understands the dynamics of our business and has the knowledge and energy to drive change in an organization that is in transformation," said President and Chief Executive Frank Witney. "As a senior leader of our international team since 2006, Gavin has consistently proven that he can do that."

Affymetrix warned last month its first-quarter revenue would miss Wall Street views due to continued headwinds in its gene expression business, particularly in Japan.

The provider of genetic analysis technologies to pharmaceutical, diagnostic and biotechnology companies also said in January it would target annual savings of roughly $25 million through a restructuring plan that included job cuts.

Mr. Barabe, who joined Affymetrix about three years ago, has held a range of financial and strategic roles in the life sciences and health-care industries, including Human Genome Sciences Inc. and Novartis AG (NVS).

Shares closed Friday at $3.69 and were inactive premarket. The stock is up 16% so far this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Affymetrix Charts.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Affymetrix Charts.